No abstract available
MeSH terms
-
Acute Disease
-
Aminoglycosides / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Antibody Formation
-
Bacterial Infections / diagnosis
-
Bacterial Infections / etiology*
-
Bacterial Infections / immunology
-
Clostridium Infections / diagnosis
-
Clostridium Infections / etiology
-
Corynebacterium Infections / etiology
-
Cytarabine / therapeutic use
-
Drug Synergism
-
Hepatitis A / diagnosis
-
Hepatitis A / etiology
-
Hepatitis B / diagnosis
-
Hepatitis B / etiology
-
Herpes Zoster / drug therapy
-
Humans
-
Immunity, Cellular
-
Legionnaires' Disease / diagnosis
-
Legionnaires' Disease / etiology
-
Leukemia / complications*
-
Leukemia / immunology
-
Methicillin / therapeutic use
-
Mycoses / diagnosis
-
Mycoses / etiology
-
Pseudomonas Infections / drug therapy
-
Staphylococcal Infections / drug therapy
-
Staphylococcal Infections / etiology
Substances
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Cytarabine
-
Methicillin